YS Biopharma Co., Ltd. YS
1.02 +1.02
Day range unavailable
52-week range unavailable
News
prnewswire.com YS Biopharma Announces Name Change to LakeShore Biopharma GAITHERSBURG, Md. , May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Results of Extraordinary General Meeting GAITHERSBURG, Md. , May 21, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer GAITHERSBURG, Md. , May 7, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
seekingalpha.com YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript YS Biopharma Co., Ltd. (NASDAQ:YS ) Q3 2024 Earnings Conference Call April 19, 2024 8:00 AM ET Company Participants Alyssa Li - Director, Investor Relations David Shao - President & Chief Executive…
prnewswire.com YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 GAITHERSBURG, Md. , April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine GAITHERSBURG, Md. , April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 GAITHERSBURG, Md. , April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine GAITHERSBURG, Md. , April 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility GAITHERSBURG, Md. , April 3, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries GAITHERSBURG, Md. , March 5, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024 GAITHERSBURG, Md. , Feb. 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting GAITHERSBURG, Md. , Feb. 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd. NEW YORK , Feb. 16, 2024 /PRNewswire/ -- Yi Zhang and shareholders representing over 59.2% of the outstanding shares of YS Biopharma Co., Ltd. (the "Company" or "YS") (NASDAQ: YS) (the "Convening…
prnewswire.com YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance GAITHERSBURG, Md. , Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces Appointment of New Directors GAITHERSBURG, Md. , Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. GAITHERSBURG, Md. , Feb. 12, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com YS Biopharma Announces US$40 Million Private Placement Financing GAITHERSBURG, Md., Feb. 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com Shareholders of YS Biopharma Announce an Extraordinary General Meeting BEIJING , Feb. 8, 2024 /PRNewswire/ -- Shareholders of YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing,…
prnewswire.com YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 GAITHERSBURG, Md. , Jan. 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.